Upcoming webinar: How is the risk classification in AML driving treatment intensity ?
We are pleased to announce that this May webinar is now open for registration. The webinar will be moderated and facilitated by leading patient advocates.
This educational webinar will give an overview on how the risk classification in AML is driving treatment intensity. This will be based on data generated in the HARMONY project.
We will be joined by:
Prof. Dr.Med Lars Bulliger
Director of the Medical Department, Division of Hematology, Oncology, and Tumor Immunology
Charité – Universitätsmedizin Berlin
ALAN Steering Committee member
Monday 8th May 2023
5:00 pm – 6:00 pm CET
Link to register:
We hope to see you !